Octreotide for the Management of Gastrointestinal Bleeding in a Patient with a HeartWare Left Ventricular Assist Device

الملخص EN

HeartWare is a third generation left ventricular assist device (LVAD), widely used for the management of advanced heart failure patients.

These devices are frequently associated with a significant risk of gastrointestinal (GI) bleeding.

The data for the management of patients with LVAD presenting with GI bleeding is limited.

We describe a 56-year-old lady, recipient of a HeartWare device, who experienced recurrent GI bleeding and was successfully managed with subcutaneous (SC) formulations of octreotide.